Dr. Stacey Clardy discusses the importance of iron and ferritin in neurology in this lab minute.

Dr. Rae Bacharach discusses the Neurology Today article, "What Neurologist Should Know About Antidepressants, Weight Gain for Neuropathy" by Gina Shaw, available in the September 19th issue of Neurology Today or at neurologytoday.com.

Show reference: https://journals.lww.com/neurotodayonline/fulltext/2024/09190/what_neurologists_should_know_about.2.aspx#:~:text=Neurologists%20frequently%20prescribe%20antidepressants%20for%20managing%20neuropathy%20and,likely%20to%20become%20nonadherent%20to%20control%20their%20weight.

In the final part of this three-part series, Dr. Halley Alexander and Dr. Gwen Zeigler discuss the management of epilepsy in transgender or gender diverse patients.

Show reference:

https://www.neurology.org/doi/abs/10.1212/CPJ.0000000000200332

Dr. Shuvro Roy and Dr. Anne Louise Oaklander discuss the big-picture takeaways for clinicians in the context of managing small-fiber neuropathy.

Show reference:

https://www.neurology.org/doi/10.1212/NXI.0000000000200286

Dr. Dara Albert and Dr. Jaclyn M. Martindale discuss the differences in gender representation among leadership positions and award recipients within the Child Neurology Society.

Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209746

In part two of this three-part series, Dr. Halley Alexander and Dr. Gwen Zeigler discuss cerebrovascular risk and management in transgender and gender-diverse patients.

Show reference: https://www.neurology.org/doi/abs/10.1212/CPJ.0000000000200332

In part one of this three-part series, Dr. Halley Alexander and Dr. Gwen Zeigler discuss the crucial aspects about managing headaches in transgender and gender-diverse patients.

Show reference: https://www.neurology.org/doi/abs/10.1212/CPJ.0000000000200332

In part two of this two-part series, Drs. Jeff Ratliff, Michiko K. Bruno, and Lawrence Golbe discuss essential advice for general neurologists who suspect a patient might have an atypical disorder.

Show reference: https://www.neurology.org/doi/full/10.1212/CPJ.0000000000200345

In part one of this two-part series, Drs. Jeff Ratliff, Michiko K. Bruno, and Lawrence Golbe discuss practical tips for recognizing when a patient's response to levodopa may indicate the need for an alternate diagnosis.

Show reference:

https://www.neurology.org/doi/full/10.1212/CPJ.0000000000200345

Drs. Gordon Smith, Shahar Shelly, and Teerin Liewluck discuss the correlation between CMAP duration and myosin loss and their effect on mortality by comparing between patients with CIM with and without myosin loss.

Show references: https://www.neurology.org/doi/10.1212/WNL.0000000000209496